Skip to Main Content

Paper Details

Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction.
Eur Heart J
19
2022
Author NameAffiliation
John G F ClelandRobertson Centre for Biostatistics and Clinical Trials, Institute of Health & Well-Being, University of Glasgow and National Heart & Lung Institute, Imperial College
Christiane E AngermannUniversity Hospital Wurzburg
Ulf Dahlstr??mLinkoping University
Ulf Dahlstr??mLinkoping University
Wan Ting Tay5 Hospital Dr
Kenneth DicksteinUniversity of Bergen, Stavanger University Hospital
Georg ErtlUniversity Hospital Wurzburg
Mahmoud HassaneinAlexandria University
Sergio V PerroneEl Cruce Hospital by Florencio Varela, Lezica Cardiovascular Institute
Mathieu Ghadanfar
Anja SchweizerNovartis Pharma AG
Achim ObergfellNovartis Pharma AG
Sean P CollinsVanderbilt University Medical Center
Gerasimos FilippatosUniversity of Cyprus, School of Medicine & National and Kapodistrian University of Athens, Attikon University Hospital
Carolyn S P LamDuke-National University of Singapore Medical School
Carolyn S P LamUniversity Medical Centre Groningen, University of Groningen
Carolyn S P Lam5 Hospital Dr
  • 1 - 17

Datasets

Release 1.2